Cargando…
Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
BACKGROUND: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. METHODS: This Retrospective, multicenter exploratory-validation analys...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833359/ https://www.ncbi.nlm.nih.gov/pubmed/31709412 http://dx.doi.org/10.1016/j.eclinm.2019.07.019 |
_version_ | 1783466367856410624 |
---|---|
author | Gratwohl, Alois Duarte, Rafael Snowden, John A. van Biezen, Anja Baldomero, Helen Apperley, Jane Cornelissen, Jan Greinix, Hildegard T. Grath, Eoin Mc Mohty, Mohamad Kroeger, Nicolaus Nagler, Arnon Niederwieser, Dietger Putter, Hein Brand, Ronald |
author_facet | Gratwohl, Alois Duarte, Rafael Snowden, John A. van Biezen, Anja Baldomero, Helen Apperley, Jane Cornelissen, Jan Greinix, Hildegard T. Grath, Eoin Mc Mohty, Mohamad Kroeger, Nicolaus Nagler, Arnon Niederwieser, Dietger Putter, Hein Brand, Ronald |
author_sort | Gratwohl, Alois |
collection | PubMed |
description | BACKGROUND: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. METHODS: This Retrospective, multicenter exploratory-validation analysis of 9103 patients, (55.5% male, median age 50 years; 1–75 years range) with an allogeneic HSCT between 2010 and 2016 from a matched sibling (N = 8641; 95%) or matched unrelated donor (N = 462; 5%) for acute myeloid (N = 6432; 71%) or acute lymphoblastic (N = 2671; 29%) leukaemia in first complete remission, and reported by 240 centres in 30 countries to the benchmark database of the European Society for Blood and Marrow Transplantation (EBMT) searched for factors associated with use of transplant techniques (standard N = 6375;70% or reduced intensity conditioning N = 2728;30%, respectively bone marrow N = 1945;21% or peripheral blood N = 7158;79% as stem cell source), and their impact on outcome. FINDINGS: Treatment groups differed significantly from baseline population (p < 0.001), and within groups regarding patient-, disease-, donor-, and centre-related pre-transplantation risk factors (p < 0.001); choice of technique did depend on pre-transplantation risk factors and centre (p < 0.001). Probability of overall survival at 5 years decreased systematically and significantly with increasing pre-transplantation risk score (score 2 vs 0/1 HR: 1·2, 95% c.i. [1·1–1·.3], p = 0.002; score 3 vs 0/1 HR: 1·5, 95% c.i. [1·3–1·7], p < 0.001; score 4/5/6 vs 0/1 HR: 1·9, 95% c.i. [1·6–2·2], p < 0.001) with no significant differences between treatment groups (likelihood ratio test on interaction: p = 0.40). Overall survival was significantly associated with selection steps and completeness of information (p < 0.001). INTERPRETATION: Patients' pre-transplantation risk factors determine survival, independent of transplant techniques. Transplant techniques should be regarded as centre policy, not stratification factor in benchmarking. Selection criteria and completeness of data bias outcome. Outcomes may be improved more effectively through better identifying pre-transplantation factors as opposed to refinement of transplant techniques. FUNDING: The study was funded by EBMT. |
format | Online Article Text |
id | pubmed-6833359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68333592019-11-08 Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia Gratwohl, Alois Duarte, Rafael Snowden, John A. van Biezen, Anja Baldomero, Helen Apperley, Jane Cornelissen, Jan Greinix, Hildegard T. Grath, Eoin Mc Mohty, Mohamad Kroeger, Nicolaus Nagler, Arnon Niederwieser, Dietger Putter, Hein Brand, Ronald EClinicalMedicine Research Paper BACKGROUND: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. METHODS: This Retrospective, multicenter exploratory-validation analysis of 9103 patients, (55.5% male, median age 50 years; 1–75 years range) with an allogeneic HSCT between 2010 and 2016 from a matched sibling (N = 8641; 95%) or matched unrelated donor (N = 462; 5%) for acute myeloid (N = 6432; 71%) or acute lymphoblastic (N = 2671; 29%) leukaemia in first complete remission, and reported by 240 centres in 30 countries to the benchmark database of the European Society for Blood and Marrow Transplantation (EBMT) searched for factors associated with use of transplant techniques (standard N = 6375;70% or reduced intensity conditioning N = 2728;30%, respectively bone marrow N = 1945;21% or peripheral blood N = 7158;79% as stem cell source), and their impact on outcome. FINDINGS: Treatment groups differed significantly from baseline population (p < 0.001), and within groups regarding patient-, disease-, donor-, and centre-related pre-transplantation risk factors (p < 0.001); choice of technique did depend on pre-transplantation risk factors and centre (p < 0.001). Probability of overall survival at 5 years decreased systematically and significantly with increasing pre-transplantation risk score (score 2 vs 0/1 HR: 1·2, 95% c.i. [1·1–1·.3], p = 0.002; score 3 vs 0/1 HR: 1·5, 95% c.i. [1·3–1·7], p < 0.001; score 4/5/6 vs 0/1 HR: 1·9, 95% c.i. [1·6–2·2], p < 0.001) with no significant differences between treatment groups (likelihood ratio test on interaction: p = 0.40). Overall survival was significantly associated with selection steps and completeness of information (p < 0.001). INTERPRETATION: Patients' pre-transplantation risk factors determine survival, independent of transplant techniques. Transplant techniques should be regarded as centre policy, not stratification factor in benchmarking. Selection criteria and completeness of data bias outcome. Outcomes may be improved more effectively through better identifying pre-transplantation factors as opposed to refinement of transplant techniques. FUNDING: The study was funded by EBMT. Elsevier 2019-08-09 /pmc/articles/PMC6833359/ /pubmed/31709412 http://dx.doi.org/10.1016/j.eclinm.2019.07.019 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Gratwohl, Alois Duarte, Rafael Snowden, John A. van Biezen, Anja Baldomero, Helen Apperley, Jane Cornelissen, Jan Greinix, Hildegard T. Grath, Eoin Mc Mohty, Mohamad Kroeger, Nicolaus Nagler, Arnon Niederwieser, Dietger Putter, Hein Brand, Ronald Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia |
title | Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia |
title_full | Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia |
title_fullStr | Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia |
title_full_unstemmed | Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia |
title_short | Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia |
title_sort | pre-transplantation risks and transplant-techniques in haematopoietic stem cell transplantation for acute leukaemia |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833359/ https://www.ncbi.nlm.nih.gov/pubmed/31709412 http://dx.doi.org/10.1016/j.eclinm.2019.07.019 |
work_keys_str_mv | AT gratwohlalois pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT duarterafael pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT snowdenjohna pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT vanbiezenanja pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT baldomerohelen pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT apperleyjane pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT cornelissenjan pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT greinixhildegardt pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT gratheoinmc pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT mohtymohamad pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT kroegernicolaus pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT naglerarnon pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT niederwieserdietger pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT putterhein pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT brandronald pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia AT pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia |